Liquidity and cash generation are adequate but not stellar relative to leverage and capex needs. TTM CFO of 2.37 billion dollars less 1.84 billion dollars in capex produced approximately 0.53 billion dollars of FCF.
Reported net debt to adjusted EBITDA is 2.24 times, within a manageable range for grocery but above the level we prefer for thin‑margin businesses. The company refinanced with new 5.5% to 5.75% senior notes due 2031–2034 and ended fiscal 2025 with total debt near 8.95 billion dollars and about 0.20 billion dollars of cash.
An opioid settlement framework of up to roughly 774 million dollars pre‑tax (booked) is payable over nine years, front‑loaded in the first two years, which modestly tightens near‑term cash flexibility. Multiemployer pension exposures remain a structural consideration, though ARP assistance has improved several funds’ status.
Dividend was raised to 0.17 dollars quarterly, and an expanded 2.0 billion dollar buyback authorization exists, but returns above FCF in fiscal 2025 were debt‑financed and should be paced prudently until free cash conversion improves.







